Authors

3D bioprinting technology facilitates development of an in vitro biomimetic bladder model

"This exciting and innovative technology has a wide range of possible applications, including tissue engineering, drug development, and precision medicine," write Kate Gessner, MD, PhD, and Philip Abbosh, MD, PhD.

Nima Almassi, MD, highlights long-term data on bladder preservation in MIBC

Nima Almassi, MD, reviews long-term evidence for bladder preservation after systemic therapy in muscle-invasive bladder cancer.

Post-surgery nivolumab boosts disease-free survival in muscle-invasive urothelial carcinoma

Adjuvant treatment with the anti–PD-1 immunotherapy significantly extended the time period after primary treatment in which patients had no signs or symptoms of cancer.

Race-based adjustment of eGFR: Current opinions and impact on urologic oncology

“As other factors such as access to care, socioeconomic conditions, patient preference, and other unknown confounders might have played a role in the observed disparity, it is still unclear whether overestimating the postoperative eGFR of Black patients contributes to the lower use of nephron-sparing approaches in this population,” the authors write.

Talazoparib/enzalutamide significantly boosts OS in mCRPC

"The TALAPRO-2 results provide much-needed hope to patients who remain in high unmet need for effective treatment options," said Neeraj Agarwal, MD, FASCO.

18F-flotufolastat PET alters treatment approach for nearly 90% of patients with recurrent prostate cancer

“Treatment based on visualization of 18F-flotufolastat–avid lesions may facilitate optimal targeting of recurrence sites and avoid futile salvage therapy,” said Przemyslaw Twardowski, MD.

Physician highlights AI’s potential to improve practice efficiency and alleviate burnout

Artificial intelligence can help curate, decipher, and contextualize the enormous and growing amount of digital data that now comprises a patient’s electronic health record, writes Nele Jessel, MD.

When a Roth conversion makes sense—and when it doesn’t

"Once money is in a Roth IRA, the withdrawal rules depend on whether the funds are contributions, conversions, or earnings," writes Julie Khazan, CFP.

FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI

The SOPHIA2 trial will assess the safety and efficacy of the UroActive implant in men with SUI.

Artificial intelligence is the new ghost author in urological research

“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.

Nivolumab/Cabozantinib combo continues to show HRQOL benefit in renal cell carcinoma

Long-term follow-up from the CheckMate 9ER trial continued to show that first-line treatment with nivolumab plus cabozantinib was associated with a health-related quality-of-life benefit over treatment with sunitinib in patients with advanced renal cell carcinoma .

Suffering from Bladder or Pelvic Floor Issues? Here’s How a Urogynecologist Can Help

Urogynecologists focus on female pelvic medicine and reconstructive surgery, handling issues related to the pelvic floor and bladder.

Novel FGFR2/3 inhibitor shows promise in solid tumors, including bladder cancer

The novel agent ABSK061 approached a response rate of 40% in patients with advanced solid tumors harboring FGFR2/3 alterations.

Is your practice equipped to battle ransomware attacks?

3 steps to protect your practice from ransomware.

Frontline masitinib combo delays progression in mCRPC with low metastatic involvement

Adding the investigational agent masitinib to standard frontline docetaxel significantly reduced the risk of disease progression or death in men with metastatic castration-resistant prostate cancer and baseline alkaline phosphatase levels (ALP) of 250 IU/mL or less.

Going “retro”: A perspective on robotic retroperitoneal renal surgery

Improvements in technology have renewed interest in the technique.

Management of hormone-naïve oligometastatic prostate cancer

Growing evidence supports the existence of an intermediate metastatic disease state.

Expert shares best practices to improve patient collections

Improving your patient payment process in 2023 is important to maintain a positive relationship with your patients and with your practice’s bottom line.

Quiz: NCCN 2019 prostate Ca guideline emphasizing germline testing

Tools urologists need to thrive in a value-based world

Practices must embark on a journey that goes beyond new technology.

Prednisone may improve total motile count post vasectomy reversal

A course of treatment with prednisone may offer improvement in mean total motile count for men who undergo vasectomy reversal and subsequently have partial or complete anastomotic obstruction, according to a recent study.

One-tenth of sperm retrievals performed by gynecologists

A recent study is questioning some of the current trends in sperm retrieval practices in private U.S. clinics that treat infertile couples.

Study: Many post-op ER visits preventable

About half of postoperative visits to emergency rooms following urologic surgery could be prevented, but simply improving patient education may not significantly reduce the number of these visits, researchers say.

Transitional Zone sampling can be spared in some men with suspicious prostate cancer lesions on mpMRI

“This zone-dependent biopsy strategy warrants prospective evaluation to optimize the extent of systematic biopsies in presence of suspicious mpMRI lesions,” the authors wrote.

Gender disparities in bladder cancer management

Poor outcomes in women may stem from diagnostic, therapeutic, and biologic factors.

Early Recurrent Low-Grade, Intermediate-Risk NMIBC

Panelists discuss how patients with early recurrent low-grade bladder cancer, especially those on an anticoagulant or with multiple risk factors, represent ideal candidates for ablative therapy with UGN-102 to break the cycle of repeated transurethral resection of bladder tumors and provide a paradigm shift from purely surgical management to shared decision-making between surgical and medical treatment options.

Urologist shares advice on maintaining a healthy screen-life balance

"The mental toll of excessive screen time is a pressing concern in health care," writes Neil Baum, MD.

FDA grants priority review to PSMA PET imaging agent 18F-DCFPyL for prostate cancer

The new drug application for 18F-DCFPyL is supported by results from the OSPREY and CONDOR trials.

Transgender education exposure low

Few urology residents receive didactic education on gender-affirming care, survey shows.